| Predicate |
Object |
| contentType |
Journal Article |
| issn |
1758-5996 |
| issueIdentifier |
1 |
| pageRange |
8- |
| publicationName |
Diabetology & Metabolic Syndrome |
| startingPage |
8 |
| bibliographicCitation |
Cobble M. Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 2012 Mar 05;4(1):8. doi: 10.1186/1758-5996-4-8. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dc4745e195f000d79bc739c427420b6 |
| date |
2012-03-05^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1186/1758-5996-4-8
https://pubmed.ncbi.nlm.nih.gov/PMC3310739
https://pubmed.ncbi.nlm.nih.gov/22390369 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35537
https://portal.issn.org/resource/ISSN/1758-5996 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/ |
| title |
Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3389c62ce3a8d167b2a3c05ee87c671a
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73352
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_33045cbeee04a3e57791bf0177468bcf
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_150023cfcf9a68d43f0f7e7798a08e14
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_195d82ce0f37600d4e0197c9a0c33d49
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8592
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_31a915532365b0a3f6119f3f19d16cf6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 |